Clinical Trial Update: A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.

View source ↗

Summary

This post-marketing surveillance study evaluated the long-term efficacy and safety of tipranavir co-administered with ritonavir in treatment-experienced HIV-1 p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Aptivus (tipranavir)
• Norvir (ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2012-08-16